Lista de obras -

Activity of cytokine-induced killer cells against bone and soft tissue sarcoma

artículo científico publicado en 2014

Adoptive immunotherapy against sarcomas.

artículo científico publicado en 2014

Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells.

artículo científico publicado en 2017

CD44v6 as innovative sarcoma target for CAR-redirected CIK cells.

artículo científico publicado en 2018

CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes

artículo científico publicado en 2020

Correction to: Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity

scientific article published on 10 October 2018

Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy

artículo científico publicado en 2018

Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells.

artículo científico publicado en 2016

Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas.

artículo científico publicado en 2013

Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity

scientific article published on 29 August 2018

Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features.

artículo científico publicado en 2013

Ex vivo allogeneic stimulation significantly improves expansion of cytokine-induced killer cells without increasing their alloreactivity across HLA barriers

artículo científico publicado en 2012

Ex vivo-activated MHC-unrestricted immune effectors for cancer adoptive immunotherapy.

artículo científico publicado en 2014

Genetically redirected T lymphocytes for adoptive immunotherapy of solid tumors.

artículo científico publicado en 2014

Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective.

artículo científico

Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity

artículo científico publicado en 2016

Specific Monoclonal Antibody Against Bcr/Abl Out-of-Frame Alternative Proteins as Diagnostic Tool in Chronic Myelogenous Leukemia Patients

artículo científico publicado en 2017

Transient proteasome inhibition as a strategy to enhance lentiviral transduction of hematopoietic CD34(+) cells and T lymphocytes: implications for the use of low viral doses and large-size vectors.

artículo científico publicado en 2011

Lista de obras de

Activity of cytokine-induced killer cells against bone and soft tissue sarcoma

Adoptive immunotherapy against sarcomas.

Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells.

CD44v6 as innovative sarcoma target for CAR-redirected CIK cells.

CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes

Correction to: Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity

Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy

Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells.

Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas.

Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity

Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features.

Ex vivo allogeneic stimulation significantly improves expansion of cytokine-induced killer cells without increasing their alloreactivity across HLA barriers

Ex vivo-activated MHC-unrestricted immune effectors for cancer adoptive immunotherapy.

Genetically redirected T lymphocytes for adoptive immunotherapy of solid tumors.

Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective.

Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity

Specific Monoclonal Antibody Against Bcr/Abl Out-of-Frame Alternative Proteins as Diagnostic Tool in Chronic Myelogenous Leukemia Patients

Transient proteasome inhibition as a strategy to enhance lentiviral transduction of hematopoietic CD34(+) cells and T lymphocytes: implications for the use of low viral doses and large-size vectors.